Anthony Mancini
Chief Global Commercialization Officer · 4 filings · Latest: Jun 16, 2026
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Jun 16, 2026 | Sale | $156.12 | 4,615 | $720.5K | 49,975 | |
RVMD | Mancini Anthony | — | Jun 15, 2026 | Proposed Sale | $153.87 | 4,211 | $647.9K | — | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | May 26, 2026 | Sale | $153.99 | 3,121 | $480.6K | 54,400 | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | May 26, 2026 | Option Exercise | $33.62 | 3,121 | $104.9K | 57,521 | |
RVMD | ANTHONY MANCINI | — | May 26, 2026 | Proposed Sale | $151.56 | 3,121 | $473.0K | — | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Apr 27, 2026 | Sale | $132.41 | 3,120 | $413.1K | 54,400 | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Apr 27, 2026 | Option Exercise | $33.62 | 3,120 | $104.9K | 57,520 | |
RVMD | ANTHONY MANCINI | — | Apr 27, 2026 | Proposed Sale | $135.30 | 3,120 | $422.1K | — | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Mar 25, 2026 | Sale | $95.56 | 37,450 | $3.6M | 54,400 | |
RVMD | Anthony Mancini | Chief Global Commercialization Officer | Mar 25, 2026 | Option Exercise | $33.62 | 37,450 | $1.3M | 91,850 | |
RVMD | Mancini Anthony | — | Mar 25, 2026 | Proposed Sale | $95.56 | 37,450 | $3.6M | — |